1 ML glatiramer acetate 20 MG/ML Prefilled Syringe — RxCUI 1111641
RxNorm drug concept · Semantic clinical drug
RxCUI 1111641
Semantic clinical drug · SCD
● Current RxNorm concept 14 FDA products
15 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1111641
Official name1 ML glatiramer acetate 20 MG/ML Prefilled Syringe
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asglatiramer acetate 20 MG per 1 ML Prefilled Syringe; glatiramer acetate 20 MG in 1 ML Prefilled Syringe
FDA products mapped14
Package NDCs mapped15
Reported Medicaid activity (SDUD)9,967 prescriptions · 38 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Glatiramer Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It's a treatment for relapsing forms of multiple sclerosis (MS) in adults. That includes a first episode that might signal MS (called clinically isolated syndrome), the classic rel...
- What exactly is glatiramer acetate used for?
- Yes, where you inject absolutely matters. You inject under the skin — never into a vein — and you should rotate your injection sites every single time. Good spots include your uppe...
- How do I give myself the injection, and does it matter where I inject?
🕸️ Concept Web — How 1 ML glatiramer acetate 20 MG/ML Prefilled Syrin... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
1 ML glatiramer acetate 20 MG/ML Prefilled Syringe
RxCUI 1111641 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Glatiramer
214582IN -
Glatiramer acetate
84375PIN
-
Glatiramer
-
Brand names 2
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Copaxone
135779BN -
Glatopa
1654626BN
-
Copaxone
-
Dose forms 12
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Glatiramer Prefilled Syringe
727577SCDF -
Glatiramer acetate Prefilled Syringe
2648324SCDFP -
Glatiramer Injectable Product
1165202SCDG -
Glatiramer acetate Injectable Product
2659780SCDGP -
Glatiramer Prefilled Syringe [Copaxone]
727580SBDF -
Glatiramer Prefilled Syringe [Glatopa]
1654628SBDF -
Glatiramer acetate Prefilled Syringe [Copaxone]
2658501SBDFP -
Glatiramer acetate Prefilled Syringe [Glatopa]
2658691SBDFP - +4 more in this family
-
Glatiramer Prefilled Syringe
-
Clinical & branded drugs 5
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Glatiramer acetate 20 MG/ML
358697SCDC -
1 ML glatiramer acetate 20 MG/ML Prefilled Syringe [Copaxone]
1111642SBD -
1 ML glatiramer acetate 20 MG/ML Prefilled Syringe [Glatopa]
1654630SBD -
Glatiramer acetate 20 MG/ML [Copaxone]
1111639SBDC -
Glatiramer acetate 20 MG/ML [Glatopa]
1654627SBDC
-
Glatiramer acetate 20 MG/ML
Showing up to 8 concepts per family — 17 of 21 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Glatiramer acetate 20 MG/ML
SCDC · 358697 -
Glatiramer Prefilled Syringe
SCDF · 727577 -
Glatiramer acetate Prefilled Syringe
SCDFP · 2648324 -
Glatiramer Injectable Product
SCDG · 1165202 -
Glatiramer acetate Injectable Product
SCDGP · 2659780
Brand-Name Concepts
-
1 ML glatiramer acetate 20 MG/ML Prefilled Syringe [Copaxone]
SBD · 1111642 -
1 ML glatiramer acetate 20 MG/ML Prefilled Syringe [Glatopa]
SBD · 1654630 -
Glatiramer acetate 20 MG/ML [Copaxone]
SBDC · 1111639 -
Glatiramer acetate 20 MG/ML [Glatopa]
SBDC · 1654627 -
Glatiramer Prefilled Syringe [Copaxone]
SBDF · 727580 -
Glatiramer Prefilled Syringe [Glatopa]
SBDF · 1654628 -
Glatiramer acetate Prefilled Syringe [Copaxone]
SBDFP · 2658501 -
Glatiramer acetate Prefilled Syringe [Glatopa]
SBDFP · 2658691 -
Copaxone Injectable Product
SBDG · 1168791 -
Glatopa Injectable Product
SBDG · 1654629
📦 FDA Products & Package NDCs
14 products · 15 package NDCs
15 package NDCs map to RxCUI 1111641 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00378-6960-93 | 30 BLISTER PACK in 1 CARTON (0378-6960-93) / 1 SYRINGE in 1... | Glatiramer Acetate | Mylan Pharmaceuticals Inc. | 2017-10-04 |
| 00781-3234-34 | 30 BLISTER PACK in 1 CARTON (0781-3234-34) / 1 SYRINGE, GLA... | Glatopa | Sandoz Inc | 2015-06-18 |
| 00781-3250-89 | 12 BLISTER PACK in 1 CARTON (0781-3250-89) / 1 SYRINGE, GLA... | Glatopa | Sandoz Inc | 2018-02-12 |
| 00832-6084-30 | 30 SYRINGE, GLASS in 1 CARTON (0832-6084-30) / 1 mL in 1 SY... | Glatiramer Acetate | UPSHER-SMITH LABORATORIES, LLC | 2026-01-23 |
| 00832-6085-12 | 12 SYRINGE, GLASS in 1 CARTON (0832-6085-12) / 1 mL in 1 SY... | Glatiramer Acetate | UPSHER-SMITH LABORATORIES, LLC | 2026-01-23 |
| 11797-0764-03 | 30 SYRINGE in 1 CARTON (11797-764-03) / 1 mL in 1 SYRINGE | GLATIRAMER ACETATE | Italfarmaco SpA | 2025-11-10 |
| 11797-0765-03 | 12 SYRINGE in 1 CARTON (11797-765-03) / 1 mL in 1 SYRINGE | GLATIRAMER ACETATE | Italfarmaco SpA | 2025-11-10 |
| 47335-0990-02 | 30 BLISTER PACK in 1 CARTON (47335-990-02) / 1 SYRINGE in 1... | Glatiramer Acetate | Sun Pharmaceutical Industries, Inc. | 2025-08-15 |
| 63629-8815-01 | 30 BLISTER PACK in 1 CARTON (63629-8815-1) / 1 SYRINGE, GLA... | Glatopa | Bryant Ranch Prepack | 2021-09-10 |
| 68546-0317-30 | 30 BLISTER PACK in 1 CARTON (68546-317-30) / 1 SYRINGE, GLA... | Copaxone | Teva Neuroscience, Inc. | 2008-04-28 |
| 68546-0325-06 | 6 BLISTER PACK in 1 CARTON (68546-325-06) / 1 SYRINGE, GLAS... | Copaxone | Teva Neuroscience, Inc. | 2014-01-29 |
| 68546-0325-12 | 12 BLISTER PACK in 1 CARTON (68546-325-12) / 1 SYRINGE, GLA... | Copaxone | Teva Neuroscience, Inc. | 2014-01-29 |
| 70710-1548-09 | 30 BLISTER PACK in 1 CARTON (70710-1548-9) / 1 SYRINGE in 1... | GLATIRAMER ACETATE | Zydus Pharmaceuticals USA Inc. | 2025-11-10 |
| 70710-1549-06 | 12 BLISTER PACK in 1 CARTON (70710-1549-6) / 1 SYRINGE in 1... | GLATIRAMER ACETATE | Zydus Pharmaceuticals USA Inc. | 2025-11-10 |
| 82983-0429-30 | 30 BLISTER PACK in 1 CARTON (82983-429-30) / 1 SYRINGE in 1... | Glatiramer Acetate | AJENAT PHARMACEUTICALS LLC | 2026-03-20 |
Observed labelers:
Teva Neuroscience, Inc. (3) ·
Italfarmaco SpA (2) ·
Sandoz Inc (2) ·
UPSHER-SMITH LABORATORIES, LLC (2) ·
Zydus Pharmaceuticals USA Inc. (2) ·
AJENAT PHARMACEUTICALS LLC (1)
· +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.